Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc G Caron

Showing results (91-100 of 232) with videos related to

Pageof 24
Sort By:
Biochemical and Biophysical Research Communications|October 7, 2006
Characterization of the desensitization properties of five dopamine receptor subtypes and alternatively spliced variants of dopamine D2 and D4 receptorsDong-Im Cho, SunRyeo Beom, Hubert H M Van Tol, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 5, 2008
Antagonism of dopamine D2 receptor/beta-arrestin 2 interaction is a common property of clinically effective antipsychoticsBernard Masri, Ali Salahpour, Michael Didriksen, et al.
The Journal of Cell Biology|August 7, 2002
Phosphoinositide 3-kinase regulates beta2-adrenergic receptor endocytosis by AP-2 recruitment to the receptor/beta-arrestin complexSathyamangla V Naga Prasad, Stéphane A Laporte, Dean Chamberlain, et al.
Biochemistry|January 3, 2015
Phenotypic regulation of the sphingosine 1-phosphate receptor miles apart by G protein-coupled receptor kinase 2Martina Burczyk, Martin D Burkhalter, Tamara Blätte, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 7, 2003
The selective serotonin-2A receptor antagonist M100907 reverses behavioral deficits in dopamine transporter knockout miceAlasdair M Barr, Virginia Lehmann-Masten, Martin Paulus, et al.
Plos One|December 15, 2012
Pregnenolone rescues schizophrenia-like behavior in dopamine transporter knockout micePeiyan Wong, Cecilia Chin Roei Chang, Christine E Marx, et al.
Journal of Cell Science|February 6, 2015
Lgr4 and Lgr5 drive the formation of long actin-rich cytoneme-like membrane protrusionsJoshua C Snyder, Lauren K Rochelle, Sébastien Marion, et al.
The Journal of Biological Chemistry|November 14, 2002
Oligomerization and trafficking of the human dopamine transporter. Mutational analysis identifies critical domains important for the functional expression of the transporterGonzalo E Torres, Ana Carneiro, Katie Seamans, et al.
Cell|July 30, 2005
An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behaviorJean-Martin Beaulieu, Tatyana D Sotnikova, Sébastien Marion, et al.
Psychoneuroendocrinology|January 21, 2015
Serotonin deficiency alters susceptibility to the long-term consequences of adverse early life experienceBenjamin D Sachs, Ramona M Rodriguiz, Ha L Tran, et al.
Pageof 24

Showing results (91-100 of 232) with videos related to

Sort By:
Pageof 24
Biochemical and Biophysical Research Communications|October 7, 2006
Characterization of the desensitization properties of five dopamine receptor subtypes and alternatively spliced variants of dopamine D2 and D4 receptorsDong-Im Cho, SunRyeo Beom, Hubert H M Van Tol, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 5, 2008
Antagonism of dopamine D2 receptor/beta-arrestin 2 interaction is a common property of clinically effective antipsychoticsBernard Masri, Ali Salahpour, Michael Didriksen, et al.
The Journal of Cell Biology|August 7, 2002
Phosphoinositide 3-kinase regulates beta2-adrenergic receptor endocytosis by AP-2 recruitment to the receptor/beta-arrestin complexSathyamangla V Naga Prasad, Stéphane A Laporte, Dean Chamberlain, et al.
Biochemistry|January 3, 2015
Phenotypic regulation of the sphingosine 1-phosphate receptor miles apart by G protein-coupled receptor kinase 2Martina Burczyk, Martin D Burkhalter, Tamara Blätte, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 7, 2003
The selective serotonin-2A receptor antagonist M100907 reverses behavioral deficits in dopamine transporter knockout miceAlasdair M Barr, Virginia Lehmann-Masten, Martin Paulus, et al.
Plos One|December 15, 2012
Pregnenolone rescues schizophrenia-like behavior in dopamine transporter knockout micePeiyan Wong, Cecilia Chin Roei Chang, Christine E Marx, et al.
Journal of Cell Science|February 6, 2015
Lgr4 and Lgr5 drive the formation of long actin-rich cytoneme-like membrane protrusionsJoshua C Snyder, Lauren K Rochelle, Sébastien Marion, et al.
The Journal of Biological Chemistry|November 14, 2002
Oligomerization and trafficking of the human dopamine transporter. Mutational analysis identifies critical domains important for the functional expression of the transporterGonzalo E Torres, Ana Carneiro, Katie Seamans, et al.
Cell|July 30, 2005
An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behaviorJean-Martin Beaulieu, Tatyana D Sotnikova, Sébastien Marion, et al.
Psychoneuroendocrinology|January 21, 2015
Serotonin deficiency alters susceptibility to the long-term consequences of adverse early life experienceBenjamin D Sachs, Ramona M Rodriguiz, Ha L Tran, et al.
Pageof 24